Introduction 21
Systemic sclerosis (SSc) is a connective tissue disease characterized by collagen overproduction by 22 altered fibroblasts and microvascular abnormalities, responsible for both skin and visceral organ 23 involvement [1] . While typical cutaneous manifestations are largely described [1] , data about the 24 involvement of the scalp in scleroderma patients are not available. Alopecia areata (AA) is a 25 common, non-scarring dermatologic condition, characterized by patches of scalp hair loss; disease 26 duration varies from self-resolving to permanent, while the distribution may be focal or widespread 27 to total body. AA is often associated to psychological morbidity that may negatively affect the 28 patient's quality of life [2, 3] . AA is a heterogeneous disorder, featured by chronic inflammation of 29 the hair follicles whose etiology remains quite unknown, and the pathogenesis is probably 30 multifactorial. The disease might be the consequence of immune-system alterations triggered by 31 different genetic, environmental, infectious, and/or physical (trauma) co-factors [3] . Clinical 32 observations revealed that patients with AA are often diagnosed together with one or more other 33 autoimmune disorders, including systemic lupus erythematosus (SLE), myasthenia gravis, 34 ulcerative colitis, vitiligo, type 1 diabetes, thyroiditis, celiac disease, and rheumatoid arthritis [3, 4] . 35
The association of AA with localized scleroderma has been also reported, while no cases of AA are 36 anti-Scl70 antibodies were found. After few years, interstitial lung disease was detected by high 45 resolution computer tomography. No significant heart involvement, including signs of pulmonary 46 hypertension at echocardiography, was found during the follow-up. The patient was firstly treated 47 with calcium channel blockers; during the following years, she presented recurrent digital ulcers, 48 thus iloprost and bosentan were added to treatment. 49
The patient's general condition remained stable until the beginning of In January 2014, the patient 50 rapidly developed hair loss, which progressively involved a large area of the scalp ( Figure 1a) ; 51 moreover, a few erythematous scaly, flaky, macular lesions appeared on the neck, the trunk, and the 52 arms. A few months earlier, the patient showed also red patches on the skin of the trunk and arms.
Thus, in the suspicion of a lupus-like cutaneous manifestation, a diagnostic skin biopsy was done; 54 histopathological examination revealed a reduction of hair follicle cells with inflammatory infiltrate 55 in and around the bulbar region of hair follicle, along with diffuse collagen infiltration of the 56 dermis, consistent with the underlying SSc; furthermore, few fungal ifae were found. On the basis 57 of these findings, the case was collegially discussed with the dermatologists, and diagnosis of AA 58 complicating SSc was done, while the presence of ifae was not sufficient to diagnose active 59 cutaneous infection. 60
Patient's serology was revaluated, excluding the presence of anti-dsDNA autoantibodies or 61 complement consumption. Overall, the suspicion of an overlapping syndrome SLE-SSc was 62 reasonably excluded. 63
After a further consultation with the dermatologists the hair loss (Figure 1b To the best of our knowledge this is the first observation of severe AA associated to SSc, even if 73 several hair disorders, including AA, can be find in different autoimmune systemic diseases and 74 localized scleroderma (3, 4, 7-9). Recent clinical investigations considered AA an autoimmune 75 disorder due to T cell-mediated hair follicle damage; in particular Xing et al. demonstrated that 76 cytotoxic CD8(+)/NKG2D(+) T cells were both necessary and sufficient for the induction of AA in 77 mouse models of disease [5] . In our case, the chronic inflammation of hair follicles due to the pre-78 existent seborrhoeic dermatitis might be considered as the 'immunologic locus' where the 79 autoimmunity against hair follicles was born, then controlled with the local and systemic 80 immunosuppressive therapy. Otherwise, a transient stressful condition as etiologic trigger could be 81 hypothesized; nonetheless, a mere coincidental coexistence of AA and SSc cannot be excluded. 82
Alopecia was firstly described in patients with localized form of scleroderma in 1962 [6] ; this 83 possible association was successively observed also in the linear subset of scleroderma "en coup de 84 sabre" and morphea [7, 8] , two conditions that only sporadically may evolve to SSc [9] . We could 85 speculate that both fibrotic and immune-mediated alterations of SSc might lead to severe injury and 86 disappearance of hair follicles, even if exceptionally, and with the possible contribution of unknown 87
co-factors. 88
No clearly effective treatments for AA are available at the present time; current management of AA 89 are primarily symptomatic and often directed to mitigate the psychological distress [2]. In our 90 patient the combined therapy with vasoactive and immunosuppressive drugs lead to valuable 91 improvement (Fig. 1c) of hair loss. Even if we can not exclude that alopecia could be improved 92 spontaneously, combined therapy with minoxidil, mycophenolate mofetil, and iloprost might 93 contributed to this improvement. However, data from literature on the therapeutic effects of 94 mycophenolate mofetil, iloprost, and other prostaglandin analogues in AA are conflicting [10, 11] . 95 96
Conclusion 97
In conclusion, the case here described might be regarded as very peculiar overlapping condition of 98 
